Avalo Therapeutics (AVTX) Net Margin (QoQ) (2016 - 2024)
Avalo Therapeutics (AVTX) Net Margin (QoQ) (2016 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Avalo Therapeutics | 854.16 Mn | 453.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.77 Mn |
| Dec 31, 2023 | 78,478.00 |
| Sep 30, 2023 | -94,107.00 |
| Jun 30, 2023 | 82,161.00 |
| Dec 31, 2021 | -3,531.00 |
| Sep 30, 2021 | 357.00 |
| Jun 30, 2021 | 2,447.00 |
| Mar 31, 2021 | -5,574.00 |
| Dec 31, 2020 | 5,116.00 |
| Sep 30, 2020 | 1,618.00 |
| Jun 30, 2020 | -7,170.00 |
| Mar 31, 2020 | -14,558.00 |
| Dec 31, 2019 | 23,261.00 |
| Sep 30, 2019 | 21,344.00 |
| Jun 30, 2019 | -17,383.00 |
| Mar 31, 2019 | -10,131.00 |
| Dec 31, 2018 | 61,612.00 |
| Sep 30, 2018 | -47,822.00 |
| Jun 30, 2018 | -3,893.00 |
| Mar 31, 2018 | 7,516.00 |